Godavari Drugs Debt & Borrowing: ₹34 Cr

Godavari Drugs Other Announcement

Godavari Drugs Limited changed its Corporate Identification Number (CIN) following an alteration to its Memorandum of Association's Object Clause. The Ministry of Corporate Affairs registered the change on October 16, 2026.

Godavari Drugs Annual General Meeting

Godavari Drugs held its 38th Annual General Meeting on September 25, 2026, via video conferencing. Shareholders approved financial statements, director re-appointment, and object clause alteration.

Godavari Drugs Annual General Meeting

Godavari Drugs Limited will close its register of members and share transfer books from September 19 to September 25, 2026, for its 38th Annual General Meeting.

Godavari Drugs Board Meeting Outcome

Godavari Drugs approved altering its Memorandum of Association to add a nutraceuticals business object. A revised notice for the 38th AGM was also approved.

Godavari Drugs Capital Structure Change

Godavari Drugs Limited allotted 7,86,690 equity shares to the promoter category following warrant conversion. The company received Rs. 5.25 Crore, representing the final 75% payment.

Value

₹5.25 Cr

Godavari Drugs Q1 FY27 Results: Net Profit ₹1.1 Cr, Up 10.0% YoY

Godavari Drugs Ltd reported revenue from operations of ₹28 Cr (+17.6% YoY) and net profit of ₹1.1 Cr (+10.0% YoY) for Q1 FY27.

Key figure

Net profit ₹1.1 Cr · +10.0% YoY

Fusion CX Debt & Borrowing: ₹21.85 Cr

Fusion CX lent up to Rs.21.85 Crore (USD 2.3 million) to wholly owned subsidiary Fusion BPO Services. Terms: 8.5% interest, three-year tenure, unsecured.

Value

₹21.85 Cr

Execution

3 years from the date of disbursal

Fusion CX Debt & Borrowing

Fusion CX Limited executed an unsecured inter-corporate term loan at 8.5% p.a. for three years with its wholly owned subsidiary Fusion BPO Services Ltd, a related party. Amount is not stated in the filing.

Execution

3 years from the date of disbursal

Spandana Sphoorty Financial Debt & Borrowing: ₹0.49 Cr

Spandana paid ₹0.49 Crore of quarterly interest on its secured NCDs on 27 October 2026. The coupon rate is 10.75% on a ₹50 Crore issue.

Value

₹0.49 Cr

Mangalam Worldwide Debt & Borrowing: ₹1.14 Cr

Mangalam Worldwide paid Rs. 1.14 Crore interest on its NCDs (ISIN INE0JYY07026) on 28 October 2026, net of TDS. The company confirmed timely payment under Regulation 57.

Value

₹1.14 Cr

Lloyds Metals & Energy Debt & Borrowing: ₹12,370 Cr

Lloyds Metals allotted 1,300 debt securities worth about ₹12,370 Crore on 29 October 2026. Three-year coupon is SOFR plus 450 bps, secured by Virtus Lloyds share pledges.

Value

₹12,370 Cr

Execution

3 years

Lloyds Metals & Energy Debt & Borrowing: ₹1,235 Cr

Lloyds Metals' committee approved terms for USD 130 million senior secured notes, about Rs.1,235 Crore. The notes mature in October 2029 at SOFR plus 450 bps.

Value

₹1,235 Cr